Alphatec Hlds

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Alphatec (ATEC) posts robust earnings, eyes growth through innovation

Alphatec (ATEC) delivered strong financial results in Q4 2022, with revenue growth, operational improvements, and a positive outlook for 2023.
The company's focus on innovation, surgeon adoption, and profitability underscores its strategic approach to sustainable growth and market leadership.
ATEC faces challenges in margin improvement, achieving EBITDA targets, and navigating competitive consolidation in the spine space.
However, the company remains optimistic, leveraging opportunities in procedural expansion, technological innovation, and international market expansion for future success.

Alphatec (ATEC) reports stellar Q1 growth and strategic acquisitions

Alphatec (ATEC) showcased robust revenue growth, strategic acquisitions, and a focus on enhancing procedural efficiency and surgeon adoption.
While challenges exist in achieving EBITDA break-even and expanding margins, ATEC's strong performance and growth outlook present promising opportunities.
The company's emphasis on technology integration, international expansion, and increasing robotics utilization positions ATEC for future success.

Alphatec (ATEC) reports robust Q2 growth and eyes international expansion

Alphatec's Q2 performance reflects strong revenue growth, margin expansion, and market share gains driven by strategic initiatives in spine surgery. The company's focus on innovation, surgeon adoption, and geographic expansion positions it well for future growth and success in the spine market.

Alphatec (ATEC) reports robust Q3 earnings, eyes growth opportunities

Alphatec (ATEC) delivered strong financial performance in Q3 2023, driven by revenue growth, positive adjusted EBITDA, and strategic initiatives.
The company's strengths lie in its spine surgery focus, new product launches, and advancements in informatics and robotic integration.
Challenges include managing risks, balancing growth with profitability, and navigating market disruptions, while opportunities exist in expansion and technology integration.

Alphatec (ATEC) reports robust Q4 performance, eyes international expansion

Alphatec (ATEC) had a strong Q4 2023, focusing on clinical excellence and market share growth. Challenges include managing debt and sustaining momentum. Opportunities lie in international expansion and innovative product launches.

Alphatec Hlds (ATEC) reports robust Q1 performance and growth outlook

Alphatec Hlds (ATEC) delivered a strong Q1 2024 performance with significant revenue growth, surgeon adoption, and sales team confidence, underpinned by a focus on innovation and market expansion.
While facing challenges in debt management and profitability, the company's strategic outlook, financial strength, and growth drivers position it well for future success and sustained growth.
By capitalizing on opportunities in technology integration, international expansion, and market share expansion, Alphatec is poised to drive continued innovation and value creation in the spine surgery market.

Alphatec Hlds (ATEC) reports robust Q2 growth and eyes Japan expansion

Alphatec Hlds (ATEC) delivered strong financial results in Q2 2024, showcasing growth in revenue, profitability, and surgeon engagement, while focusing on innovation and clinical distinction.
The company faces challenges in achieving cash flow break-even, entering new markets like Japan, and expanding into deformity surgery, but sees opportunities in market growth and technological advancements.
Overall, Alphatec Hlds (ATEC) remains committed to advancing spine surgery through technology, attracting surgeons to advanced tools, and driving sustainable growth through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

24/7 Wall St. Insights With a market rotation underway, where should investors seeking opportunities in health care be looking?

Prediction: This Health Care Stock Will Be the Best Performer the Rest of 2024

Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q2 2024 Results Conference Call July 31, 2024 4:30 PM ET Company Participants Patrick Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Vik Chopra - Wells Fargo Eric Anderson - TD Cowen Matt Blackman - Stifel Drew Ranieri - Morgan Stanley Aaron Wukmir - Lake Street Capital Markets David Saxon - Needham & Co. Jason Wittes - ROTH Sean Lee - H.C. Wainwright Operator Good afternoon, everyone, and welcome to the webcast of ATEC's Second Quarter Financial Results.

Alphatec Holdings, Inc. (ATEC) Q2 2024 Earnings Call Transcript

Alphatec (ATEC) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.43 per share a year ago.

Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2024, and recent corporate highlights. Second Quarter 2024 Financial Results Quarter Ended June 30, 2024 Total revenues $ 146   GAAP gross margin   71 % Non-GAAP gross margin   71 % Operating expenses $ 138   Non-GAAP operating expenses $ 114   GAAP net loss $ (41.

ATEC Reports Second Quarter 2024 Financial Results And Raises Full-Year Guidance

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The RBC West Coast Medical Device Bus Tour at the Estancia Hotel in La Jolla, CA, on August 14, 2024, at 2:45pm PT The Piper Sandler MedTech and Diagnostics California Bus Tour at the Ritz Carlton in Dana Point, CA, on August 21, 2024, at 10.

ATEC to Present at Upcoming Conferences

Alphatec (ATEC) announces the commercial launch of its EOS Insight, an end-to-end spine surgery platform powered by standardized EOSedge scans and artificial intelligence.

Alphatec's (ATEC) New EOS Insight System to Boost Spine Care

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the commercial launch of EOS Insight, a groundbreaking, end-to-end spine surgery platform powered by standardized EOSedge™ scans and AI. With the first customer implementation complete, the EOS Insight-informed surgeries were successfully performed at OrthoIndy Hospital by David G. Schwartz, MD, and Craig McMain.

ATEC Launches EOS InsightTM, an End-To-End Spine Surgery Platform Powered by EOS Imaging and AI

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2024 financial results on July 31, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the l.

ATEC to Report Second Quarter Financial Results on July 31, 2024

Alto Neuroscience Inc

Navitas Semiconductor Corp

One of the best ways to be successful in the stock market is by identifying under-the-radar stocks before they blow up. All of today's biggest and most valuable companies were once entirely unknown.

Wake Up! 3 Lesser-Known Stocks Investors Are Sleeping On

Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Patrick Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Joshua Jennings - TD Cowen David Saxon - Needham Vik Chopra - Wells Fargo Sean Lee - H.C. Wainwright Young Li - Jefferies Operator Good afternoon everyone and welcome to the webcast of ATEC's First Quarter Financial Results.

Alphatec Holdings, Inc. (ATEC) Q1 2024 Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2024, and recent corporate highlights. First Quarter 2024 Financial Results   Quarter Ended March 31, 2024 Total revenue $138 million GAAP gross margin 70% Non-GAAP gross margin 71% GAAP operating expenses $141 million Non-GAAP operating expenses $115 million GAA.

ATEC Reports First Quarter 2024 Financial Results and Raises Full-Year Guidance

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2024 financial results on May 7, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live.

ATEC to Report First Quarter Financial Results on May 7, 2024

Stryker

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years. “The addition of Emory adds even further con.

Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

Bumble

Crescent Energy

HighPeak Energy Inc

Schrodinger 

Tandem Diabetes Care

Zai Lab Ltd.

Small cap stocks like those discussed below tend to receive much less attention than their large cap competitors. Shares, which boast a market capitalization between $250 million and $2 billion, remain relatively small.

Shhh! 7 Small-Cap Stocks That Can Double by 2025

ACM Research

Catalyst Pharmaceuticals

If you want big returns, you gotta think small – as in small-cap stocks. That's not to say the large-capitalization enterprises can't get you to investment Valhalla.

3 Sexy Small-Cap Stocks to Add Sizzle to Your Portfolio

Alphatec Holdings, Inc. (ATEC) Q4 2023 Earnings Call Transcript

Alphatec (ATEC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.33 per share a year ago.

Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and full year ended December 31, 2023, and business highlights. Fourth Quarter and Full Year 2023 Financial Results Quarter EndedDecember 31, 2023 Year EndedDecember 31, 2023 Total revenues $ 138   $ 482   GAAP gross margin   69.0 %   64.3 % Non-GAAP gross margin (prior definiti.

ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights

In recent years, Alphatec Holdings has outperformed expectations on a regular basis and successfully taken share in the $8 billion U.S. spinal disorder treatment market. The company is capitalizing on M&A-related disruptions at key competitors, which has created opportunities for Alphatec to grab additional market share. Persistent cash usage has resulted in substantial debt accumulation and material dilution for common shareholders, but the company appears adequately financed to reach cash flow breakeven by 2025.

Alphatec Holdings: Taking Market Share Amid Strong Execution - Buy

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary revenue results for the fourth quarter and full-year ended December 31, 2023, and provided revenue guidance for full-year 2024. Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue Ranges   Fourth Quarter Ended December 31, 2023 Full-Year Ended December 31, 2023 Surgical Revenue $121.8M t.

ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will present at the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, CA, at 3:45pm PT on January 10, 2024. Both the live webcast and the presentation materials will be available on the Investor Relations Section of the Company's website. About ATEC ATEC, through.

ATEC to Present at the 2024 J.P. Morgan Healthcare Conference

Alphatec Holdings, Inc.'s focus on growth rather than improving margins raises caution for investors. Despite strong revenue growth, the company continues to experience substantial losses and slow progress on margin improvements. The recent share sales and high debt levels contribute to investor uncertainty about the company's commitment to shareholder value.

Alphatec: Still Not Having My Back

Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Pat Miles - Chairman and Chief Executive Officer Todd Koning - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Matt Blackman - Stifel Matthew O'Brien - Piper Sandler Joshua Jennings - TD Cowen Drew Ranieri - Morgan Stanley Sean Lee - H.C. Wainwright Jason Wittes - ROTH Operator Good afternoon, everyone and welcome to the webcast of ATEC's Third Quarter Financial Results.

Alphatec Holdings, Inc. (ATEC) Q3 2023 Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2023, and recent corporate highlights. Third Quarter 2023 Financial Results   Quarter Ended September 30, 2023 Total revenue $118 million GAAP gross margin 68% Non-GAAP gross margin 72% GAAP operating expenses $118 million Non-GAAP operating expenses $94 mill.

ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor events: The Stifel Healthcare Conference at the Lotte New York Palace Hotel in New York, NY, with a fireside chat at 3:00pm ET on November 14, 2023 The Jefferies London Healthcare Conference at the Waldorf Hilton in Aldwych, London, with a fireside chat.

News for Alphatec Hlds Stock (ATEC)